Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/IDOGEN-AB-PUBL-107928966/news/Idogen-AB-Announces-First-Patient-Enters-Idogen-s-Hemophilia-Study-Under-the-Ido-8-Program-42013383/?utm_source=whatsapp&utm_medium=social&utm_campaign=share